STOCK TITAN

Health Catalyst, Inc - HCAT STOCK NEWS

Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.

Health Catalyst, Inc. (Nasdaq: HCAT) is a leading provider of data and analytics technology and services to healthcare organizations. Founded by healthcare veterans, the company specializes in building comprehensive data warehousing and process improvement solutions, aiming to significantly enhance healthcare delivery. Health Catalyst's innovative solutions are powered by its adaptive data architecture, which uses a late-binding bus model for agile and quick implementation.

The company operates primarily through two segments: Technology and Professional Services. The Technology segment is the key revenue driver, providing data platforms, analytics applications, and support services under cloud-based subscriptions, time-based licenses, and maintenance agreements. The Professional Services segment offers analytics, implementation, strategic advisory, outsourcing, and improvement services, enabling clients to maximize the utility of Health Catalyst's technological offerings.

Health Catalyst has recently gained recognition with several achievements:

  • VitalCDM: Ranked number one in the Revenue Cycle - Chargemaster Management category of the 2024 Best in KLAS: Software & Services.
  • MeasureAble™: Achieved ONC-Health IT 2015 Edition Certification, allowing its use for various quality reporting programs.
  • Able Health Registry: Received QPP Qualified Registry approval for the 2024 performance year from CMS.
  • Acquisition of Carevive Systems: Strengthened their capabilities in oncology data analytics, improving patient care and outcomes.

Financially, Health Catalyst continues to show promising trends, with forward-looking revenue and EBITDA guidance indicating growth. The company frequently updates its investors through quarterly earnings calls and reports, reflecting transparency and financial health.

Health Catalyst envisions a future where all healthcare decisions are data-informed, leveraging a cloud-based data platform encompassing over 100 million patient records and trillions of data points. This commitment to data-informed decision-making is at the core of its mission to drive measurable improvements in clinical, financial, and operational metrics for healthcare organizations.

For more information, visit the Health Catalyst Investor Relations page.

Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT), a leading provider of data and analytics technology for healthcare organizations, has announced its plans to release second quarter 2024 operating results on Wednesday, August 7, 2024, after market close. The company will host a conference call at 5 p.m. E.T. on the same day to review the results.

Participants can join the call by dialing 800-267-6316 (U.S.) or 203-518-9783 (international) with the conference ID "HCATQ224". A live audio webcast will be available at https://ir.healthcatalyst.com/, with a replay accessible shortly after the call for approximately 90 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
conferences earnings
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) has secured a $225 million credit facility with Silver Point Finance. The facility includes an initial $125 million term loan and a $100 million delayed draw option. The company will use the funds to refinance existing convertible notes due in 2025 and support its growth strategy.

CEO Dan Burton emphasized the importance of this non-dilutive capital for pursuing organic and inorganic growth opportunities. CFO Jason Alger highlighted the flexibility of the financing structure, allowing Health Catalyst to address near-term debt maturity while focusing on creating shareholder value and maintaining a strong balance sheet.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.19%
Tags
none
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) has completed its acquisition of Carevive Systems, a health technology company specializing in oncology. Carevive's platform is used for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and post-treatment care. This acquisition will enhance Health Catalyst's capabilities in oncology care and patient-reported outcomes. Both companies aim to leverage data and analytics to improve patient care and outcomes. The integration promises to deliver innovative solutions to cancer centers and provide researchers with valuable real-world data.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT), a top provider of data and analytics technology in healthcare, announced its participation in key investor conferences. CFO Jason Alger and VP of Investor Relations Jack Knight will represent the company.

They will attend The Stifel Cross Sector Insight Conference in Boston, featuring a fireside chat on June 4, 2024, at 9:45am ET. Additionally, they will present at The Goldman Sachs 45th Annual Global Healthcare Conference in Miami, scheduled for June 12, 2024, at 8:40am ET.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
conferences
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) has launched Health Catalyst Ignite®, a next-generation data and analytics ecosystem designed for the healthcare sector. The platform integrates advanced technologies, healthcare-specific data models, self-service tools, and industry expertise to address the challenges of data management in healthcare. Ignite offers seamless integration, scalability, and flexibility, reducing costs and improving decision-making. It enables data sharing, centralizes data governance, and democratizes analytics to provide faster insights and enhanced control. The platform supports a range of healthcare use cases, from clinical improvement to operational efficiency, leveraging AI and machine learning for predictive insights.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.1%
Tags
none
-
Rhea-AI Summary

Health Catalyst, Inc. reported strong financial results for the first quarter of 2024, with total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, beating guidance mid-points. The company remains focused on long-term profitability goals and reaffirmed its full-year guidance for 2024. Key metrics show growth in gross profit and margins, with a 1% increase in total revenue year over year. However, there was a 19% decrease in Adjusted EBITDA compared to the same period last year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.9%
Tags
Rhea-AI Summary
Health Catalyst, Inc. will announce its first quarter 2024 operating results on May 9, 2024, after market close. The company will host a conference call to review the results at 5 p.m. E.T. on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.68%
Tags
-
Rhea-AI Summary
Health Catalyst, Inc. (HCAT) to participate in investor conferences with leadership members discussing key financial and strategic insights.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.85%
Tags
conferences
-
Rhea-AI Summary
Health Catalyst announces UnityPoint Health as the winner of the 2024 Flywheel Award for outstanding healthcare transformation achievements, showcasing significant cost savings and revenue enhancements through data and analytics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.81%
Tags
none
Rhea-AI Summary
Health Catalyst's 2024 Healthcare Analytics Summit (HAS) in Salt Lake City gathers 1,000 global healthcare leaders to explore data and analytics in healthcare transformation. Keynotes by industry experts and sessions on AI, patient care, cost optimization, and more aim to drive innovation and impact.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.64%
Tags
none

FAQ

What is the current stock price of Health Catalyst (HCAT)?

The current stock price of Health Catalyst (HCAT) is $5.68 as of January 21, 2025.

What is the market cap of Health Catalyst (HCAT)?

The market cap of Health Catalyst (HCAT) is approximately 338.6M.

What does Health Catalyst, Inc. do?

Health Catalyst provides data and analytics technology and services aimed at enhancing healthcare delivery through comprehensive data warehousing and process improvement solutions.

What are the main segments of Health Catalyst's business?

The main segments are Technology, which includes data platforms and analytics applications, and Professional Services, which offers analytics, implementation, strategic advisory, and improvement services.

What recent achievements has Health Catalyst made?

Health Catalyst's recent achievements include the top ranking of VitalCDM in the 2024 Best in KLAS, ONC-Health IT certification for MeasureAble™, QPP Qualified Registry approval for Able Health Registry, and the acquisition of Carevive Systems.

What is the adaptive data architecture?

The adaptive data architecture is a late-binding bus model that provides agility and flexibility, allowing quick implementation of data solutions tailored specifically for healthcare data complexities.

How does Health Catalyst generate its revenue?

Revenue is primarily generated through cloud-based subscription arrangements, time-based licensing, and maintenance and support fees.

What is the Best in KLAS ranking?

Best in KLAS is an annual report that recognizes top-performing software and services companies in healthcare, based on client feedback and evaluations.

What is the significance of the MeasureAble™ ONC-Health IT certification?

The certification allows MeasureAble™ to be used for various quality reporting programs, ensuring compliance with U.S. Department of Health and Human Services standards.

How does the acquisition of Carevive Systems benefit Health Catalyst?

The acquisition enhances Health Catalyst's oncology data analytics capabilities, improving patient care and providing insights into patient-reported outcomes and oncology registry data.

How does Health Catalyst support its clients?

Health Catalyst supports its clients through a combination of advanced data platforms, analytics software, and professional services to drive measurable improvements in clinical, financial, and operational metrics.

Where can I find more information about Health Catalyst's financial performance?

You can find detailed financial information and updates on Health Catalyst's Investor Relations page at https://ir.healthcatalyst.com/.
Health Catalyst, Inc

Nasdaq:HCAT

HCAT Rankings

HCAT Stock Data

338.62M
59.26M
2.68%
90.79%
4.2%
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States of America
SOUTH JORDAN